Titan Pharmaceuticals, Inc. (TTNP)
Oct 2, 2025 - TTNP was delisted (reason: merged into BTTC).
4.610
-0.180 (-3.76%)
Inactive · Last trade price
on Oct 1, 2025
Titan Pharmaceuticals Employees
Titan Pharmaceuticals had 4 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$701,250
Market Cap
6.13M
Employees Chart
TTNP News
- 4 months ago - TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP - Business Wire
- 5 months ago - Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock - GlobeNewsWire
- 6 months ago - Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd. - GlobeNewsWire
- 8 months ago - Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd. - GlobeNewsWire
- 2 years ago - Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria - GlobeNewsWire
- 2 years ago - Titan Pharmaceuticals Announces Reverse Stock Split and Ratio - GlobeNewsWire